BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26987311)

  • 1. Exploring the implications of distinct mutational signatures and mutation rates in aging and cancer.
    Fox EJ; Salk JJ; Loeb LA
    Genome Med; 2016 Mar; 8(1):30. PubMed ID: 26987311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clock-like mutational processes in human somatic cells.
    Alexandrov LB; Jones PH; Wedge DC; Sale JE; Campbell PJ; Nik-Zainal S; Stratton MR
    Nat Genet; 2015 Dec; 47(12):1402-7. PubMed ID: 26551669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signatures of mutational processes in human cancer.
    Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
    Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutation in cancer and normal cells.
    Martincorena I; Campbell PJ
    Science; 2015 Sep; 349(6255):1483-9. PubMed ID: 26404825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding mutagenesis through delineation of mutational signatures in human cancer.
    Petljak M; Alexandrov LB
    Carcinogenesis; 2016 Jun; 37(6):531-40. PubMed ID: 27207657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection.
    Yadav VK; DeGregori J; De S
    Nucleic Acids Res; 2016 Mar; 44(5):2075-84. PubMed ID: 26883632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational signatures of redox stress in yeast single-strand DNA and of aging in human mitochondrial DNA share a common feature.
    Degtyareva NP; Saini N; Sterling JF; Placentra VC; Klimczak LJ; Gordenin DA; Doetsch PW
    PLoS Biol; 2019 May; 17(5):e3000263. PubMed ID: 31067233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related somatic mutations in the cancer genome.
    Milholland B; Auton A; Suh Y; Vijg J
    Oncotarget; 2015 Sep; 6(28):24627-35. PubMed ID: 26384365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SigsPack, a package for cancer mutational signatures.
    Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
    BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. decompTumor2Sig: identification of mutational signatures active in individual tumors.
    Krüger S; Piro RM
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):152. PubMed ID: 30999866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SomaMutDB: a database of somatic mutations in normal human tissues.
    Sun S; Wang Y; Maslov AY; Dong X; Vijg J
    Nucleic Acids Res; 2022 Jan; 50(D1):D1100-D1108. PubMed ID: 34634815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct mutation accumulation rates among tissues determine the variation in cancer risk.
    Hao D; Wang L; Di LJ
    Sci Rep; 2016 Jan; 6():19458. PubMed ID: 26785814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic Methods to Identify Mutational Signatures in Cancer.
    Islam SMA; Alexandrov LB
    Methods Mol Biol; 2021; 2185():447-473. PubMed ID: 33165866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs.
    Ng AS; Chan DKH
    Oncogene; 2023 Sep; 42(37):2713-2724. PubMed ID: 37573406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting genetic and environmental mutation signatures with model organisms.
    Segovia R; Tam AS; Stirling PC
    Trends Genet; 2015 Aug; 31(8):465-74. PubMed ID: 25940384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The shaping of cancer genomes with the regional impact of mutation processes.
    Lee SY; Wang H; Cho HJ; Xi R; Kim TM
    Exp Mol Med; 2022 Jul; 54(7):1049-1060. PubMed ID: 35902761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data.
    Bertl J; Guo Q; Juul M; Besenbacher S; Nielsen MM; Hornshøj H; Pedersen JS; Hobolth A
    BMC Bioinformatics; 2018 Apr; 19(1):147. PubMed ID: 29673314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?
    DeGregori J
    Oncogene; 2013 Apr; 32(15):1869-75. PubMed ID: 22751134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Mosaicism and Cancer: Cause and Effect.
    Lichtenstein AV
    Cancer Res; 2018 Mar; 78(6):1375-1378. PubMed ID: 29472519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation Signatures Depend on Epigenomic Contexts.
    Coleman N; De S
    Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.